Hans-Ewald Hohmeier

Hans-Ewald Hohmeier (MD) is Associate Professor in the Department of Medicine at Duke University in Durham, NC and a member of the Duke Molecular Physiology Institute. He trained at the Medical School Hannover, Germany and did his thesis work in Immunochemistry with Dr. N. Hilschmann at the Max-Planck Institute for Experimental Medicine in Goettingen, Germany. In 1992, he joined the Touchstone Center for Diabetes Research at UT Southwestern Medical Center in Dallas, TX as a postdoctoral fellow training with Drs. J.D. Capra and C.B. Newgard. With Dr. Newgard he studied pathways of glucose-stimulated insulin secretion in the beta-cell and mechanisms to protect beta-cells against cytotoxic and lipotoxic stressors. During the following 6 years he worked at a Biotechnical company, Beta-Gene Inc. in Dallas, TX, where he managed research efforts to develop engineered cell lines for the treatment of metabolic diseases. In 2002 Dr Hohmeier joined Duke University. His research investigates factors that control function and viability of mature islet beta-cells and how these factors can be exploited to prevent the loss of beta-cell mass and function in diabetes.

Back to Editorial Board